Ever Fortune. AI Co

Ever Fortune. AI Co CROIC

The Cash Return on Invested Capital (CROIC) of Ever Fortune. AI Co (6841.TWO) as of Oct 21, 2026 is -1.80 %. In the previous year, Cash Return on Invested Capital (CROIC) was 0.69 % — a change of -360.01% (lower).

CROIC

-1.80 %

YoY

-360.01%

Last updated:

Cash Return on Invested Capital (CROIC) of Ever Fortune. AI Co is 2025 -1.80 % . Cash Return on Invested Capital (CROIC) of Ever Fortune. AI Co was 2024 0.69 % . It decreases by -360.01% lower compared to the previous year.

The Ever Fortune. AI Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-1.80 TWD
Jan 1, 2019
-1,180.93 TWD
Jan 1, 2020
-2.97 TWD
Jan 1, 2021
-4.84 TWD
Jan 1, 2022
-4.14 TWD
Jan 1, 2023
-2.40 TWD
Jan 1, 2024
0.69 TWD
Jan 1, 2025
-1.80 TWD
The Ever Fortune. AI Co CROIC history
YEARCROICYoY
-1.80 %-360.01%
0.69 %-128.77%
-2.40 %-41.86%
-4.14 %-14.49%
-4.84 %+62.70%
-2.97 %-99.75%
-1,180.93 %+65,669.92%
-1.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ever Fortune. AI Co Stock analysis

What does Ever Fortune. AI Co do? Ever Fortune.AI Co., Ltd. generates revenue through the sale of medical AI software products and customized technology solutions. The company offers medical big data platforms, cloud biomedical services, and AI-driven tools such as the radiographic bone age-assisted interpretation system, ultrasound breast tumor auxiliary classification system, and CT liver cancer metastasis risk management system. These products target healthcare providers, hospitals, and medical institutions seeking advanced diagnostic and analytical capabilities. The firm's focus on specialized medical AI applications ensures consistent demand from clients requiring precision in radiology, oncology, and cardiology. The company's revenue streams include the provision of medical AI data analysis services and tailored AI technology solutions for healthcare facilities. Products like the liver fibrosis evaluation system and irregular cardiac fibrillation interpretation system are designed to address specific clinical needs, enhancing diagnostic accuracy. Healthcare organizations, particularly those in radiology and cardiology departments, purchase these tools to improve patient outcomes and operational efficiency. Ever Fortune.AI's business model centers on delivering high-value AI solutions for medical diagnostics, with a portfolio that includes both standardized products and custom-developed systems. The firm's offerings cater to hospitals and medical institutions looking to integrate AI into their diagnostic workflows. By focusing on niche medical applications, the company establishes itself as a specialized provider in the healthcare technology sector. Ever Fortune. AI Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ever Fortune. AI Co stock

Cash Return on Invested Capital (CROIC) of Ever Fortune. AI Co is -1.80 % in 2025.

Cash Return on Invested Capital (CROIC) of Ever Fortune. AI Co changed from 0.69 % to -1.80 %, representing a -360.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Ever Fortune. AI Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Ever Fortune. AI Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ever Fortune. AI Co

All Key Metrics — Ever Fortune. AI Co